Home › News
Updated every other day
Latest Peptide News
Original reporting on the peptide industry — FDA actions and compounding decisions, supply and shortage changes, new clinical trial results, and peer-reviewed research on the peptides people actually track. Published every other day, sourced to primary documents, and written for people managing a protocol rather than for clinicians.
Peptide News
How this page is made. PeptideWiz News covers regulatory actions,
published research, and industry developments from a fixed list of primary sources
— the FDA, NIH, EMA, ClinicalTrials.gov, PubMed, peer-reviewed journals, and
company press rooms. Articles are drafted with AI assistance from those sources,
reviewed before publication, and always link to the original. Read the full
editorial standards & corrections policy.
This is journalism about peptides, not medical advice: it does not recommend any
substance, does not state dosages, and is not a substitute for your provider.